An interventional study of Beat-accentuated, personalized music stimulation (BMS) and Strength Training (ST) in Alzheimer Disease and Physical Activity, sponsored by Emory University. Recruiting at 2 sites in United States. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-30.
Sponsored by Emory University · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Alzheimer Disease by Emory University — 6 open to participants now, 6 under way, none of them phase 3. Alzheimer Disease · Emory University.
Among the 28 studies in Alzheimer Disease by Emory University, this one is the 8th largest by planned enrollment of the 25 interventional ones that give a count, is one of 2 that started in 2024, is one of 19 with no phase, and was the 24th registered.
3,972 studies on the registry are indexed under Alzheimer Disease; 930 are open to participants now.
Browse Alzheimer Disease studies →6 of the 28 studies in Alzheimer Disease by Emory University are open now, in 1 country. Recruiting first, the newest first:
Emory University · Sites in United States
Ages 18+ · Healthy volunteers
Emory University · Sites in United States
Ages 50–90
Emory University · Sites in United States
Ages 18–79 · Healthy volunteers
Emory University · Sites in United States
Ages 50–90
Emory University
Ages 18+
By country, each count listing its studies:
Of the 645 Alzheimer Disease studies recruiting now, 282 (44%) set no upper age limit and 57 (9%) stop at 75 or younger; 34 take children under 18; 288 take healthy volunteers.
This study: 65 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 4 2
First in 2003; this study’s year is marked. 2 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 70 across 3,022 interventional studies indexed under Alzheimer Disease.
Median enrollment 50 across the 25 interventional studies, 135 across the 3 observational. Of the 20 that completed or were terminated, 9 (45%) have results posted.
This tab as a report to print or save as PDF → With an account.
Emory University is the lead sponsor of 1,406 studies on the registry; 224 are open to participants now.
Of its 238 completed or terminated interventional studies of FDA-regulated products, 179 (75%) have results posted.
1 of the studies in Alzheimer Disease by Emory University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06484244Emory UniversityLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 28 studies in Alzheimer Disease by Emory University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to test the benefits of beat-accented music stimulation (BMS) for behavioral changes of physical activity (PA) in older adults with subjective memory complaints. Specific Aims are to determine (1) whether BMS beneficially influences PA behaviors and psychological responses to PA in older adults for 6 months, and (2) whether exercising with BMS differently influences physical and cognitive functioning as well as quality of life in older adults. To test the effects of BMS on PA, participants will be randomly assigned to an exercise intervention that either includes BMS or does not include BMS. Participants will attend a supervised group strength training (ST) (30 minutes per day) and aerobic exercise (AE) (30-50 minutes per day) session for 3 days per week for the first 2 months, 1 day per week for the next 2 months (while encouraging participants to independently perform both AE and ST on other days), and independently for the final 2 months (always with a goal of performing >150minutes per week AE and 3 days per week of ST for 30 minutes per day).
Regular physical activity (PA) is associated with numerous health benefits including improved muscular and cardiorespiratory fitness, cognitive functioning, and quality of life (QoL). Hence, national PA guidelines (PAG) have been disseminated to recommend regularly engaging in moderate-to-vigorous aerobic exercise (AE) and muscle-strengthening training (ST). However, adherence to the PAG steeply declines after ages 60-65,1-5 at the time when health benefits of PA become pronounced. Fewer than 20% of US older adults adhere to the national guidelines for both AE and ST.
PA promotion is particularly urgent in older adults who are experiencing subjective cognitive complaints (SCC) and thereby have a heightened risk of Alzheimer's disease. SCC refers to self-perceived worsening of memory or other cognitive capacities in the previous year, independent of cognitive testing or clinical diagnosis, and is known to be an important prognostic symptom of Alzheimer's Disease (AD). According to the latest national survey, \~10% of US adults aged > 45 years reported SCC and, of those with SCC, 43.6% do not engage in any PA outside of work.
A major challenge to promoting multicomponent PA is that many sedentary people have a negative affective attitude toward moderate AE and ST. This negative affective response is a critical barrier to the maintenance of regular PA because, in general, people are unlikely to continue a behavior that results in immediate displeasure. Listening to music during acute bouts of PA increases positive effects and reduces perceived exertion. However, for these benefits to translate to long-term adherence, music alone is not sufficient. Beat-accented music stimulation (BMS) is an application of pulsed, tempo-synchronous music stimuli for the facilitation of rhythmic body movements. BMS has shown effects on increasing the weekly volume of PA in midlife-to-older adults undergoing cardiac rehabilitation whereas beat-unaccented music had little effect on PA outcomes. This proof-of-concept has not been tested in low-active older adults and the psychological mechanisms of PA behavior change remain unknown.
Participants will be randomized to an exercise intervention with or without BMS (MEX vs. EX), both offering the same exercise prescription to foster independent adherence to the PAG through the gradual withdrawal of supervised training. The exercise intervention lasts for 6 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cognitively unimpaired, physically low-active older adults with subjective cognitive complaints are provided with a 6-month exercise intervention with beat-accentuated, personalized music stimulation (BMS).
Behavioral: Beat-accentuated, personalized music stimulation (BMS) · Behavioral: Strength Training (ST) · Behavioral: Aerobic exercise (AE)
Cognitively unimpaired, physically low-active older adults with subjective cognitive complaints are provided with a 6-month exercise intervention without beat-accentuated, personalized music stimulation (BMS).
Behavioral: Strength Training (ST) · Behavioral: Aerobic exercise (AE)
Participants receive pre-recorded music playlists to use during exercise. During the strength training (ST), participants are asked to sync their concentric and eccentric muscle contractions to the beats of the music at a specific tempo. During aerobic exercise (AE), the tempo is adjusted to match individual walking cadence for participants to step in sync with the playlists.
Most exercises for the ST are chair- or wall-assisted to be safely performed by older adults on their own and adaptable across fitness levels by using different resistance bands. ST are taught at in-person and virtual sessions. Repetitions are increased by 1 repetition every 2 to 3 weeks up to 1 set of 12 repetitions. Participants start the program using no band or the lowest-resistance band. Band level is increased gradually, individually for each participant, to help reduce the risk of injury and prevent excessive fatigue.
At the beginning of the program, participants are asked to exercise 45 minutes per week spread over 3 sessions (15 minutes per session). Beginning at Week 4, a 5-minute increase in walking time per session occurs every 2 weeks until 30 minutes of walking is reached per session. Beginning at Week 10 the number of sessions per week increases until participants walk for 30 minutes 5 times per week, for a total of 150 minutes per week. Minutes per session and total minutes per week are guidelines. Participants may choose to increase or decrease daily or weekly exercise time based on their individual needs. Participants may choose to perform AE more than 150 minutes per week.
Changes of physical activity behaviors as assessed by ActiGraph wGT3X-BT
Duration, intensity, and frequency of physical activity assessed using a waist-worn accelerometer.
Time frame: 7 consecutive days at Baseline (before the intervention) and during month 1, 2, 3, 4, 5, and 6
Affective responses to physical activity as assessed by Physical Activity Enjoyment Scale (PACES)
Self-reported affective states relative to physical activity. Physical Activity Enjoyment Scale has 18 items based on a 7-point Likert scale and the total score ranges from 18 to 126.
Time frame: At baseline (before the intervention), month 3 and month 5 during the intervention, and post-test (within 4 weeks after the intervention)
Affective attitude toward physical activity, perceived exertion, planned and actual physical activity, and physical activity settings
Concurrent, prospective, and retrospective affective attitude toward physical activity, perceived exertion, planned and actual physical activity, and physical activity settings as assessed by Ecological Momentary Assessment.
Time frame: 4 days at baseline and months 1, 2, 3, 4, 5, and 6
Adherence to the physical activity program
Daily duration of aerobic exercise and strength training is self-reported on an exercise log.
Time frame: A daily exercise log for the entire 6-month period
General cognition as assessed using the Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment takes approximately 10 minutes for completion and the total score ranges from 0 to 30.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Executive function as assessed using the Tower of London - Freiburg version
Tower of London - Freiburg version takes approximately 14 minutes to complete and measures the total number of items solved in minimum number of moves in the range from 0 to 12.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Executive function as assessed using the NIH Toolbox Flanker Inhibitory Control and Attention test
The Flanker Inhibitory Control and Attention test takes approximately 5 minutes to complete and measures the accuracy and reaction time to create a composite score, ranging from 0 to 10.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Executive function as assessed using the NIH Toolbox Dimensional Change Card Sort test
The Dimensional Change Card Sort test takes approximately 5 minutes to complete and measures the accuracy and reaction time to create a composite score, ranging from 0 to 10.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Executive function as assessed using the NIH Toolbox List Sorting Working Memory test
The List Sorting Working Memory test takes approximately 10 minutes to complete and measures the total number of items correctly recalled and sequenced, ranging from 0 to 26.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Episodic memory as assessed using the NIH Toolbox Picture Sequence Memory test
The Picture Sequence Memory test takes approximately 7 minutes to complete and measures the total number of items correctly placed, ranging from 0 to 31, and the IRT-based theta score, ranging from 200 to 700.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Episodic memory as assessed using the Mnemonic Similarity Task
This custom-developed test takes approximately 15 minutes to complete and measures mnemonic discrimination (a score ranging from 0-1) and visual recognition (a score ranging from 0-1).
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Health-related quality of life as assessed using the RAND 36-Item Short-Form Health Survey (SF-36)
The RAND 36-Item Short-Form Health Survey Scale has 36 items for self-report, takes 10-15 minutes to complete, and measures health-related quality of life with a score ranging from 0 - 100.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Physical activity behaviors as assessed by physical activity and sedentary behavior questionnaire
The physical activity and sedentary behavior questionnaire has 7 items and takes approximately 5 minutes for completion.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
The progress of aerobic capacity and endurance as assessed by 6-minute walk test
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
The progress of balance, sit-to-stand, and walking as assessed by Timed Up and Go test
The time taken to complete a Timed Up and Go test is an indicator of fall risks.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
The progress of lower-body strength as assessed by 30-Second Sit-to-Stand test
The number of sit-to-stand maneuvers completed in 30 seconds.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
The progress of upper-body strength as assessed by Grip Strength test
The squeeze power in pounds measured by a handheld dynamometer.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
The progress of balance as assessed by 4-Stage Balance Test
The duration of maintaining 4 difference postures.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Individual differences in music-related reward experiences as assessed by the Barcelona Music Reward Questionnaire (BMRQ)
BMRQ has 24 items and takes 5-10 minutes to complete and measures music-related reward experiences with a score ranging from 0 to 100.
Time frame: At pre-test (before the intervention) and post-test (within 4 weeks after the intervention)
Treatment satisfaction as assessed by the iSTEP Satisfaction Survey (iSTEP-SS)
iSTEP-SS has 25 items and takes up to 5 minutes to complete and measure participants' perceived accessibility, social support, confidence, and satisfaction with the intervention.
Time frame: At post-test (within 4 weeks after the intervention)
Not enrolling at this site.
Plan to share: No
Started May 2024 (actual). Primary completion is estimated for Oct 2026, 29 months after the start.
Of 887 non-industry interventional studies with no phase under Alzheimer Disease, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 51. This study's planned 29 months is close to that.
Counting every sponsor, half of 964 studies reached it within 29 months; a quarter within 15 and three quarters within 51.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.